GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 424 filers reported holding GLOBUS MED INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,493 | -16.6% | 30,077 | 0.0% | 0.03% | -22.2% |
| Q2 2023 | $1,791 | +5.1% | 30,077 | 0.0% | 0.04% | 0.0% |
| Q1 2023 | $1,704 | -23.7% | 30,077 | 0.0% | 0.04% | -28.0% |
| Q4 2022 | $2,234 | -99.9% | 30,077 | 0.0% | 0.05% | +13.6% |
| Q3 2022 | $1,792,000 | +6.1% | 30,077 | 0.0% | 0.04% | +10.0% |
| Q2 2022 | $1,689,000 | +27.9% | 30,077 | +67.9% | 0.04% | +2.6% |
| Q1 2022 | $1,321,000 | +2.2% | 17,909 | 0.0% | 0.04% | +8.3% |
| Q4 2021 | $1,293,000 | +23.5% | 17,909 | +31.1% | 0.04% | -7.7% |
| Q3 2021 | $1,047,000 | -1.1% | 13,662 | 0.0% | 0.04% | -9.3% |
| Q2 2021 | $1,059,000 | +25.6% | 13,662 | 0.0% | 0.04% | +16.2% |
| Q1 2021 | $843,000 | -5.4% | 13,662 | 0.0% | 0.04% | -11.9% |
| Q4 2020 | $891,000 | +146.8% | 13,662 | +87.3% | 0.04% | -12.5% |
| Q3 2020 | $361,000 | – | 7,295 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
| Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
| Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
| Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
| Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
| XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
| Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
| RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
| Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |